Updates

National Coalition on Health Care highlights the impact of rising specialty drug prices

Apr 24, 2015

Originally published on AmericanPharmacyNews.com. Read More

Are Skyrocketing Drug Prices Really Needed for Innovation?

Apr 22, 2015

Are Skyrocketing Drug Prices Really Needed for Innovation? Amgen’s… Read More

ICYMI: National Journal article features CSRxP’s White Paper

Apr 21, 2015

This morning, the National Journal published an article regarding an increase in public concern over the high cost of prescription drugs. The article references CSRxP’s white paper, “Specialty Drug Hyperinflation: The Risk to Patients and the Health Care System.” Read More

Vertex’s Kalydeco combo could run payers $10M-plus per life, PBM figures

Apr 13, 2015

Sky-high drug prices have been causing their fair share of consternation among payers lately, and industry watchers have suspected for a while now that Vertex ($VRTX) will stir the pot when its new cystic fibrosis combo--expected to win FDA approval later this year--hits the market. But just how much will payers need to shell out for the new med over time? Prime Therapeutics has some ideas. Read More

Congressional Briefing Resources

Apr 9, 2015

April 09, 2015 Congressional Briefing Resources Peter Bach, MD… Read More

The Impact of Rising Drug Costs on Patients, Providers and Public Programs

Apr 9, 2015

The Campaign for Sustainable Rx Pricing (CSRxP), a project of the National Coalition on Health Care, is hosting a Congressional briefing on Thursday, April 9. Read More

CSRxP Congressional Briefing

Apr 2, 2015

CSRxP Congressional Briefing The Impact of Rising Drug Costs on Patients,… Read More

Congressional Briefing Panelist Bios

Apr 2, 2015

Keynote Speaker Peter Bach, MD, MAPP Director The system wide impact of new… Read More

New Drug Report Confirms Drug Prices On Unsustainable Path

Mar 11, 2015

Reaction from National Coalition on Health Care President and CEO John Rother… Read More

Speaking Engagements Broaden Discussion on Unsustainable Drug Prices

Feb 24, 2015

John Rother to Make Appearances at AMA National Advocacy Conference and National Conference of Insurance Legislators. Read More

CVS girds for battle over cholesterol drugs

Feb 17, 2015

Drug retail giant CVS Health Corp. is girding to do battle with pharmaceutical companies over a coming class of cholesterol drugs that CVS says could cost the nation’s health-care system $150 billion a year. Read More

On health-care prices, Obama goes where Obamacare doesn’t

Feb 9, 2015

Ever since Obamacare took effect, Republicans have warned of mission creep: that a law bringing more government regulation to health care would eventually morph into single-payer. Read More